17191838.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Functional Anatomy of the Hypothalamic–Pituitary–Gonadal Axis and 1 the Male Reproductive Tract
Cambridge University Press 978-1-107-01212-7 - Fertility Preservation in Male Cancer Patients Editor-in-Chief John P. Mulhall Excerpt More information Section 1 Anatomy and physiology Chapter Functional anatomy of the hypothalamic–pituitary–gonadal axis and 1 the male reproductive tract Nelson E. Bennett Jr. Anatomy of reproductive function The reproductive functional axis of the male can be divided into three major subdivisions: (1) the hypo- thalamus, (2) the pituitary gland, and (3) the testis. Each level elaborates a signal, or transmitter molecule, that stimulates or inhibits the subsequent level of the axis. The end result is the production and expulsion of semen that contains spermatozoa. This chapter exam- ines the hypothalamic–pituitary–gonadal (HPG) axis, and reviews the functional anatomy of the testis, epi- didymis, vas deferens, seminal vesicles, prostate, and penis. Hypothalamus and anterior pituitary gland The control of male sexual and reproductive func- tion begins with secretion of gonadotropin-releasing hormone (GnRH) by the hypothalamus (Fig. 1.1). This hormone in turn stimulates the anterior pituitary gland to secrete two downstream hormones (termed gonadotropins). These hormones are luteinizing hor- mone (LH) and follicle-stimulating hormone (FSH). LH is the primary stimulus for the testicular secre- tion of testosterone, while FSH mainly stimulates spermatogenesis. Gonadotropin-releasing hormone (GnRH) Figure 1.1. Feedback regulation of the hypothalamic– The neuronal cells of the arcuate nuclei of the hypo- pituitary–gonadal (HPG) axis in males. Positive (stimulatory) effects are shown by + and inhibitory (negative feedback) effects by –. thalamus secrete GnRH, a 10-amino-acid peptide. The GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; endingsoftheseneuronsterminateinthemedian FSH, follicle-stimulating hormone. -
Male Sexual Impotence: a Case Study in Evaluation and Treatment
FAMILY PRACTICE GRAND ROUNDS Male Sexual Impotence: A Case Study in Evaluation and Treatment John G. Halvorsen, MD, MS, Craig Mommsen, MD, James A. Moriarty, MD, David Hunter, MD, Michael Metz, PhD, and Paul Lange, MD Minneapolis, Minnesota R. JOHN HALVORSEN {Assistant Professor, De cavernosa. There is also a very important suspensory lig D partment o f Family Practice and Community ament—a triangular structure attached at the base of the Health)-. Male sexual impotence is the inability to obtain penis and to the pubic arch blending with Buck’s fascia and sustain an erection adequate to permit satisfactory around the penis—that is responsible for forming the angle penetration and completion of sexual intercourse. Im of the erect penis. potence is defined as primary if erections have never oc The arterial supply to the penis flows from the aorta curred, and secondary if they have previously occurred through the common iliac, hypogastric, and internal pu but subsequently have ceased. The cause of sexual im dendal systems. The artery of the penis is a branch of the potence may be psychogenic, organic, or mixed. In the internal pudendal artery and has four branches. The first past, the common belief was that 90 percent of impotence branch, the artery to the bulb, supplies the corpus spon was psychological.1,2 Recent research indicates, however, giosum, the glans, and the bulb. The second branch is the that over one half of men with impotence suffer from an urethral artery. The artery of the penis then terminates organic disorder, although often there is considerable into the dorsal artery of the penis (which supplies the deep overlap between both psychological and organic causes.3,4 fascia, the penile skin, and the frenulum) and the deep or A knowledge of the anatomy of the penis and the com profunda branch (which supplies the corpora cavernosa plex physiology of erection is necessary to understand the on each side). -
Vascularization of the Penis of a Man
Roczniki Akademii Medycznej w Białymstoku · Vol. 49, 2004 · Annales Academiae MedicaeVascularization Bialostocensis of the penis of a man 285 Vascularization of the penis of a man Okolokulak E, Volchkevich D The Human Anatomy Department, Grodno State Medical University, Grodno, Belarus Abstract Conclusions: The penis receives blood from external and internal pudendal arteries, which are very variable. The Purpose: The study of the features of the blood supply of venous blood of the penis flows off in three types of veins. a penis of the man. Material and methods: Macromicropreparation, angio- graphy, corrosion method, morphometry, statistical method. Key words: penis, veins of penis, arteries of penis, erectile Results: The penis has three venous collector-execut- dysfunction. ing outflow of blood. First of them is submitted surface dorsal vein, which is shaped from small-sized venous ves- sels of skin, subcutaneous fat and surface fascia of penis. Introduction The beginning deep dorsal vein, which will derivate second venous collector, gives veniplex of head of the penis. The The development of the medical technology has deepened spongy veins outstanding as third venous collector, reach the knowledge of organic violations of gears of erection. It was the bulb of penis, where they receive small-sized bulbar vein. straightened out, that more than 50% from them cause vascular The arterial blood supply of penis happens at the expense of disorders [1-4]. It has given a particular push to more detailed external and internal pudendal arteries. The external puden- learning extra- and intraorgans vessels of the penis. At the same dal artery starts from an internal wall of femoral artery on time, the problems of vascularization and relationships of blood 2.5-2.7 cm below inguinal ligament. -
Evaluation on the Effects of Hydrocolloids on Sensory, Texture and Color Properties of Mulberry Pastille
242 October, 2019 AgricEngInt: CIGR Journal Open access at http://www.cigrjournal.org Vol. 21, No. 3 Evaluation on the effects of hydrocolloids on sensory, texture and color properties of mulberry pastille Nosrat Azimi1, Shadi Basiri2*, Ali Mortazavi3 (1. MSc of Food Science and Technology, Sabzevar Branch, Islamic Azad University; 2. Assistant professor, Agricultural Engineering Research Department , Khorasan Razavi Agricultural and Natural Resources Research Center, AREEO, Mashhad, Iran; 3. Professor, Food Science and Technology Department, Faculty of Agriculture, Ferdowsi University of Mashhad, Iran) Abstract: White mulberry is a fruit with high nutritional quality. The shelf life of Mulberry is short due to high moisture content. In this research, a new product from white Mulberry called pastille was formulated. Two hydrocolloid ingredients: guar (0%, 0.5% and 1%) and gelatin (0%, 1% and 2%) were used for pastille formulations. Parameters such as color parameters (L* a* b*), sensory evaluations and texture profile analysis (TPA) of samples were investigated. The results of texture evaluation showed that springiness, chewiness, adhesiveness and hardness increased by increasing gelatin, while cohesiveness decreased. Hardness and adhesiveness decreased by addition of the guar. Hardness and adhesiveness decreased with adding guar. Sensory evaluation showed that increasing of the hydrocolloids led to the decrease of acceptability scores. The parameters of a* and b* of pastille samples increased with increasing hydrocolloids concentration, however L* values decreased when the amount of hydrocolloids increased. Mulberry pastille including 1% guar and 1% gelatin having the lowest amount of hardness, adhesiveness, chewiness and suitable color characteristics, was determined as the best formulation among the other investigated samples. -
Celebrating the Rich History of Waxes Bladel, the Netherlands What’S Inside: Watertown, Connecticut, Usa
CELEBRATING THE RICH HISTORY OF WAXES BLADEL, THE NETHERLANDS WHAT’S INSIDE: WATERTOWN, CONNECTICUT, USA 2-3 – HERITAGE 4-5 – INNOVATION 6-7 – WORLD RESOURCES 8-9 – NATURAL/ORGANIC 10-11 – SILICONYL WAXES 12-13 – CUSTOM BLENDS 14-15 – EMULSIFYING WAXES 16-17 – KESTER WAXES 18-19 – MILKS 20-41 – WAX SPECIFICATIONS 42 – WAX PROPERTIES KOSTER WAX FACT: Koster Keunen was founded in the Netherlands and is world renowned for supplying quality waxes. 1852 OUR HISTORY OF TRADITION AND INNOVATION Founded in 1852 as a family business, Koster Keunen has evolved into the world’s leading processor, refiner and marketer of natural waxes. From the early days of sun bleaching beeswax for the candle industry, we now specialize in processing and formulating quality waxes for cosmetics, pharmaceutical, food, coatings, and various other technical industries worldwide. For over 150 years we have sought perfection, constantly introducing new and innovative processes and waxes, while investing in experienced, knowledgeable people and the best equipment to help meet this goal. As a family business we believe very strongly in the need for developing 3 superior quality products, and supporting our customers with excellent service, throughout the formulation and marketing processes. From our two facilities, in the USA and Holland, we offer a huge range of natural waxes, synthetic waxes and wax derivatives, enabling our customers to produce thousands of products that look, feel and work superbly KOSTERKEUNEN.COM / 1 860.945.3333 KOSTER WAX FACT: Koster Keunen was the first natural wax company to manufacture waxes using a Sandvik Pastillator, starting in 1988. 1852 UNIQUELY KOSTER KEUNEN Our greatest strength is the experience and scientific expertise we have fostered for the development of new and innovative products. -
SŁOWNIK ANATOMICZNY (ANGIELSKO–Łacinsłownik Anatomiczny (Angielsko-Łacińsko-Polski)´ SKO–POLSKI)
ANATOMY WORDS (ENGLISH–LATIN–POLISH) SŁOWNIK ANATOMICZNY (ANGIELSKO–ŁACINSłownik anatomiczny (angielsko-łacińsko-polski)´ SKO–POLSKI) English – Je˛zyk angielski Latin – Łacina Polish – Je˛zyk polski Arteries – Te˛tnice accessory obturator artery arteria obturatoria accessoria tętnica zasłonowa dodatkowa acetabular branch ramus acetabularis gałąź panewkowa anterior basal segmental artery arteria segmentalis basalis anterior pulmonis tętnica segmentowa podstawna przednia (dextri et sinistri) płuca (prawego i lewego) anterior cecal artery arteria caecalis anterior tętnica kątnicza przednia anterior cerebral artery arteria cerebri anterior tętnica przednia mózgu anterior choroidal artery arteria choroidea anterior tętnica naczyniówkowa przednia anterior ciliary arteries arteriae ciliares anteriores tętnice rzęskowe przednie anterior circumflex humeral artery arteria circumflexa humeri anterior tętnica okalająca ramię przednia anterior communicating artery arteria communicans anterior tętnica łącząca przednia anterior conjunctival artery arteria conjunctivalis anterior tętnica spojówkowa przednia anterior ethmoidal artery arteria ethmoidalis anterior tętnica sitowa przednia anterior inferior cerebellar artery arteria anterior inferior cerebelli tętnica dolna przednia móżdżku anterior interosseous artery arteria interossea anterior tętnica międzykostna przednia anterior labial branches of deep external rami labiales anteriores arteriae pudendae gałęzie wargowe przednie tętnicy sromowej pudendal artery externae profundae zewnętrznej głębokiej -
API & Dosage Form Development
API and Dosage Development W I T H D A LT O N Peter Pekos [ C O M P A N Y V I S I O N ] "To make the impossible possible. Dalton Pharma Services uses its scientific and pharmaceutical expertise to bring customer ideas to life. We develop their new drug products, optimize the synthesis of therapeutic candidates, and manufacture them at the highest level of quality." [ S E R V I C E S ] Contract Research Custom Synthesis Medicinal and Flow Chemistry API Process Development Formulation Development cGMP API Manufacturing cGMP Sterile Filling Analytical and Microbiology Services FDA inspected, HC approved, & MRA with EMA API Form Development API Definition Active pharmaceutical ingredient (API) – the substance(s) in pharmaceutical drugs that is/are responsible for the beneficial health effects experienced by consumers. (1) API Selection Key factors that drive API selection (2): Crystallinity: Influences the dissolution rate and transport characteristics of the drug (3) Polymorphism: The ability of a drug substance to Solubility: take on more than one form/ The ability of a solute to dissolve in crystalline phase. Influences drug solvent. Influences desired dissolution and drug stability (i.e., concentration and drug premature degradation) (4) absorption (6) Density: Influences flow properties and Stability: compressibility (5) Influenced by moisture, excipients, temperature, pH, oxygen, light (7) Particle size distribution: Influences the ability of the drug to Density: cross blood barriers, enter cells, Influences flow properties and and absorbed by the human body compressibility (5) (2) The development stage and needs API & CTD Note: In any clinical application or new drug submission the 1) description of manufacturing (including flowcharts) is required along with 2) physiochemical characteristics (melting point, boiling point, denaturation temperature, solubility) (2.3.S.2, 2.3.S.3 and 2.3.P.3) (4) Once the API form is determined, the dosage form must be selected. -
Novel Dry Powder Inhaler Formulation Containing Antibiotic Using Combined Technology to Improve Aerodynamic Properties
Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties Rita Ambrus 1* , Edit Benke 1, Árpád Farkas 2, Imre Balásházy 2, Piroska Szabó-Révész 1 1Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary 2Centre for Energy Research, Hungarian Academy of Sciences, Budapest, Hungary *Corresponding author: [email protected] Abstract Dry Powder Inhaler (DPI) could offer a propellant-free, easy-to-use powder form ensuring better stability than liquid dosage forms. Therefore the development of traditional carrier-based and carrier-free new generation systems is a determinative factor in the field of DPI formulation. The purpose of our research work was to combine these two systems, utilizing their beneficial properties to produce a novel pulmonary drug delivery system containing ciprofloxacin hydrochloride (CIP). Co-spray drying, surface smoothing and the preparation of an interactive physical mixture were applied as the technological procedures of sample preparation. The carrier-based and carrier-free formulations, as well as the developed novel product were compared to each other. Structural investigations were made by X-ray powder diffraction and micrometric properties (habit, bulk density) were determined. Particle interactions were also evaluated to investigate surface free energy, cohesive-adhesive forces, and spreading coefficient. In vitro aerodynamic properties (mass median aerodynamic diameter, fine particle fraction (FPF) and emitted dose of DPIs were measured using Andersen Cascade Impactor. A novel in silico Stochastic Lung Model was also used to quantify the amount of particles deposited at the target area. The novel-formulated composition presented amorphous spherical particles with an average size of about 2 µm. -
Randomised, Double-Blind, Placebo-Controlled Study of A
J Pharm Pharmaceut Sci (www.cspsCanada.org) 15(2) 281 - 294, 2012 Randomised, Double-Blind, Placebo-Controlled Study of a Single Dose of an Amylmetacresol/2,4-dichlorobenzyl Alcohol Plus Lidocaine Lozenge or a Hexylresorcinol Lozenge for the Treatment of Acute Sore Throat Due to Upper Respiratory Tract Infection Damien McNally,1 Adrian Shephard,2 Emma Field3 1 Ormeau Health Centre, Belfast, UK; 2 Professional Relations, Reckitt Benckiser, Slough, UK; 3 Global Medical Affairs, Reckitt Benckiser Healthcare, Hull, UK. Received, January 31, 2012; Revised, February 24, 2012; Accepted, April 1, 2012; Published, April 2, 2012. ABSTRACT - Purpose: Sore throat is a frequent reason for seeking medical care but few prescription options are available. Lozenges are effective in delivering active ingredients to the throat. This study was conducted to determine the analgesic efficacy of two lozenges one containing amylmetacresol (AMC)/2,4- dichlorobenzyl alcohol (DCBA) and lidocaine and one containing hexylresorcinol versus placebo in patients with acute sore throat due to upper respiratory tract infection (URTI). Methods: This was a multicentre, randomised, double-blind, parallel group, placebo-controlled study. In total, 190 patients were randomised 1:1:1 to a single dose of AMC/DCBA + lidocaine, hexylresorcinol or placebo lozenge. Subjective ratings of throat soreness, difficulty swallowing, swollen throat, numbing, and sore throat relief were obtained up to 2 hours post dose. Patient and investigator global ratings and a consumer questionnaire -
Modification.Pdf
ADD THIS SLIDE Rupture of the Urethra Rupture of the urethra resulted from a severe blow on the perineum. Site of rupture 1-At bulb of the penis, just below the perineal membrane. The urine extravasates into the superficial perineal pouch and then passes forward over the scrotum beneath the membranous layer of the superficial fascia. 2-Membranous part of the urethra is ruptured, urine escapes into the deep perineal pouch and extravasate upward around the prostate and bladder or downward into the superficial perineal pouch. IN BOOTH CASES The urine cannot passes into thigh because attachment of colles fascia with fasciae lata below inguinal ligament Dr Ahmed Salman CANCELLED FROM 6)Internal pudendal artery It leaves the pelvis through the greater sciaticMID foramen TERM and enters ONLYthe gluteal region below the piriformis muscle . It then enters the perineum by passing through the lesser sciatic foramen and passes forward in the pudendal canal with the pudendal nerve. Branches : In The pudendal canal 1- Inferior rectal. 2- Perineal . Which gives Two scrotal (or iibial) arteries Transverse perineal A In deep perineal pouch 3-Artery of the bulb 4-Urethral artery In the superficial perineal pouch 5-Dorsal artery of the penis 6-Deep artery of the penis Dr Ahmed Salman Other arteries in the pelvis Superior Rectal Artery The superior rectal artery is a direct continuation of the inferior mesenteric artery at the common iliac artery. It supplies the mucous membrane of the rectum and the upper half of the anal canal. Ovarian Artery The ovarian artery arises from the abdominal part of the aorta at the level L2. -
Anatomy and Blood Supply of the Urethra and Penis J
3 Anatomy and Blood Supply of the Urethra and Penis J. K.M. Quartey 3.1 Structure of the Penis – 12 3.2 Deep Fascia (Buck’s) – 12 3.3 Subcutaneous Tissue (Dartos Fascia) – 13 3.4 Skin – 13 3.5 Urethra – 13 3.6 Superficial Arterial Supply – 13 3.7 Superficial Venous Drainage – 14 3.8 Planes of Cleavage – 14 3.9 Deep Arterial System – 15 3.10 Intermediate Venous System – 16 3.11 Deep Venous System – 17 References – 17 12 Chapter 3 · Anatomy and Blood Supply of the Urethra and Penis 3.1 Structure of the Penis surface of the urogenital diaphragm. This is the fixed part of the penis, and is known as the root of the penis. The The penis is made up of three cylindrical erectile bodies. urethra runs in the dorsal part of the bulb and makes The pendulous anterior portion hangs from the lower an almost right-angled bend to pass superiorly through anterior surface of the symphysis pubis. The two dor- the urogenital diaphragm to become the membranous solateral corpora cavernosa are fused together, with an urethra. 3 incomplete septum dividing them. The third and smaller corpus spongiosum lies in the ventral groove between the corpora cavernosa, and is traversed by the centrally 3.2 Deep Fascia (Buck’s) placed urethra. Its distal end is expanded into a conical glans, which is folded dorsally and proximally to cover the The deep fascia penis (Buck’s) binds the three bodies toge- ends of the corpora cavernosa and ends in a prominent ther in the pendulous portion of the penis, splitting ven- ridge, the corona. -
Manufacture and Characteristics of Pastilles and Their Coating by Crystallization Process
MANUFACTURE AND CHARACTERISTICS OF PASTILLES AND THEIR COATING BY CRYSTALLIZATION PROCESS DISSERTATION zur Erlangung des akademischen Grades Doktor-Ingenieur (Dr.-Ing.) genehmigt durch die Mathematisch-Naturwissenschaftlich-Technische Fakultät (Ingenieurwissenschaftlicher Bereich) der Martin-Luther-Universität Halle-Wittenberg von Herrn M.Sc. Jung-Woo Kim geb. am 20.08.1972 in KyoungNam / Süd Korea Dekan der Fakultät: Prof. Dr. Ludwig Staiger Gutachter: 1. Prof. Dr. -Ing. habil. Joachim Ulrich 2. Prof. Dr. habil. Karsten Mäder 3. Dr. -Ing. Ulrich Teipel Halle (Saale), den 15. 12. 2003 urn:nbn:de:gbv:3-000006229 [http://nbn-resolving.de/urn/resolver.pl?urn=nbn%3Ade%3Agbv%3A3-000006229] CONTENTS CONTENTS 1. INTRODUCTION ……………………………………………......…………... 1 2. TECHNICAL BACKGROUND AND THEORY ………………………….. 3 2.1. Melt solidification ……………………………………………………..... 3 2.1.1. Technical background of melt solidification processes ………..…. 3 2.1.2. Approximation of crystallization rate ………………………..…… 5 2.1.3. Degree of deformation ………………………………………..…... 5 2.2. Porosity ……………………………………………………………..…... 7 2.3. Nucleation and crystal growth in solution …………………………..….. 11 2.3.1. Nucleation ……………………………………………………..….. 11 2.3.1.1. Types of nucleation …………………………………..……... 11 2.3.1.2. Kinetic of nucleation …………………………………..……. 12 2.3.1.3. Surface nucleation ……………………………………..……. 14 2.3.2. Growth rate …………………………………………………..…… 16 2.3.2.1. Theory of crystal growth ………………………………..…... 16 2.3.2.2. Kinetic of crystal growth ………………………………..…... 17 2.4. Agglomeration mechanism ………………………………………...…….. 19 2.5. Interfacial tension …………………………………………………..……. 21 2.6. Seeding technology ………………………………………………..…….. 23 3. STATE OF ART AND OBJECTIVES OF THESIS ………………....…….. 24 3.1. State of art …………………………………………………………..…... 24 3.1.1. Crystallization time of drops ………………………………..…….. 24 3.1.2. Coating mechanism in a crystallization process ……………..…… 25 3.1.2.1.